Florida Receives $4.3M to Help Rehabs Like Legacy Healing Center Combat the Opioid Epidemic

To provide "multifaceted support" for the treatment of opioid use disorder amidst the national opioid epidemic.

The Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S. Department of Health and Human Services, is set to distribute an additional $4.3 million to organizations across Florida to provide “multifaceted support” for the treatment of opioid use disorder amidst the national opioid epidemic. So far, SAMHSA has provided $123 million nationally to help healthcare providers and communities combat substance use disorder.

The main focus of this round of funding for opioid use disorder treatment is for Medication-Assisted Treatment for Prescription Drug and Opioid Abuse (MAT-PDOA), also known as medically-assisted treatment (MAT).

MAT programs provide a highly effective long-term treatment for opioid use disorder.  MAT can have a lasting impact on brain function, by improving brain function and preventing relapse while simultaneously addressing the root causes of substance abuse through evidence-based behavioral therapies.

Florida remains a hotbed in the opioid epidemic.  The state saw an alarming 59 percent increase in drug overdose deaths from 2019 to 2020, according to preliminary data released in the Project Opioid Tampa Bay report which called the opioid problem in Florida “the epidemic within the pandemic”.

The impact of the COVID-19 pandemic on mental health, substance use disorder, and recovery is still being felt by individuals and communities across Florida. The government funding for effective treatment for opioid use disorder in Florida aims to help offset the devastation that the COVID-19 pandemic has had on addiction rates and to continue providing support to those suffering from opioid use disorder.

David Levin, Chief Clinical Officer and CEO of Legacy Healing Center which operates in Florida and New Jersey, commented on the effects of the COVID-19 pandemic on addiction.  “The disease of addiction metastasizes in isolation. And we are especially vulnerable and susceptible to depression, anxiety, and relapse because of the isolation, because of the quarantine, because of the fear, because of the disconnection. [The COVID-19 pandemic] has had a tremendous impact and it’s affecting everybody,” he said.

Legacy Healing Center, a SAMHSA-recognized addiction treatment center, provides MAT programs and holistic treatment models that can help a person out of addiction and mental health disorders. With the new round of funding for treatment, the professional help Floridians need to overcome opioid use disorder is now more available than ever.

Anyone struggling with substance abuse can speak to a treatment specialist at any time by calling (888) 534-2295.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy